Global Tuberculosis Vaccine Treatment Market Report By Test (Tuberculin Skin Test (TST), TB Blood Tests, Igras (Interferon-Gamma Release Assays), Others), By TB Vaccines (Immunotherapeutic Vaccines, Booster Vaccines, Others), By End Users (Hospitals, Private Clinics, Research Institutes, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2022-2030

As per this study the Global Tuberculosis Vaccine Treatment Market was valued USD 50.76 MN (by revenue) in 2022 and is anticipated to reach USD 85.08 MN by 2030 with a CAGR of 6.67%.
 
Tuberculosis (TB) is the contagious disease caused by bacteria Mycobacterium tuberculosis that mainly affects lungs. It leads to multisystem infection and in the severe case may lead to death. Hence, tuberculosis vaccines are used to prevent the population from tuberculosis. Various vaccines are available to prevent the disease but Bacillus Calmette–Guérin (BCG) vaccine is the most popular and effective vaccine till date.
 
Market Dynamics
 
The rapid proliferation of tuberculosis among the population has generated high demand for tuberculosis vaccines treatment. Favorable initiatives and awareness campaign was taken by various governments to reduce the prevalence of tuberculosis are further fueling the market growth. Also, improving healthcare infrastructure coupled with a rising inclination towards prevention of disease over cure is further boosting the market growth. Growing demand for advanced TB vaccines owing to rising cases of drug-resistant TB infection is further pushing the market growth uphill.  
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of tuberculosis vaccine treatment.
 
Market Segmentation
 
The broad tuberculosis vaccine treatment market has been sub-grouped into type of test, type of tuberculosis vaccine and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Test

• Tuberculin Skin Test (TST)
• TB Blood Tests
• Igras (Interferon-Gamma Release Assays)
• Others

By TB Vaccines

• Immunotherapeutic Vaccines
• Booster Vaccines
• Others

By End Users

• Hospitals
• Private Clinics
• Research Institutes
• Others

Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for tuberculosis vaccine treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Tuberculosis Vaccine Treatment Market Share by Region (Representative Graph)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Tuberculosis Vaccine Treatment market include Merck & Co. Inc.(US), Sanofi Pasteur SA (France), Serum Institute of India Pvt. Ltd. (India), GlaxoSmithKline plc (UK), IDT Biologics GmbH, GreenSignal Bio Pharma Limited (India), Taj Pharmaceuticals Limited (India), Bavarian Nordic(US), Solvay(US), Informa plc.(US) and Others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.